Hypertension Drug Market – Survey on Health Impacts 2023 | Novartis, Pfizer, Lupin, GlaxoSmithKline

Hypertension is a condition where the systolic blood pressure rises over 140 mmHg and diastolic blood pressure over 90 mmHg. The precise cause of hypertension is unknown; however, factors such as smoking, obesity, stress, excess sodium, old age, sleep apnea, certain hormonal conditions, kidney diseases, sedentary lifestyle, poor diet, lack of exercise, and drugs & alcohol contribute to the incidence of hypertension.

According to the Centers for Disease Control and Prevention (CDC), hypertension was the primary reason for the death of more than 410,000 Americans in 2014. Hypertension is a long-term disease, and thus requires daily administration of antihypertensive drugs, which is anticipated to drive the hypertension drug market.

Download Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/2647?utm_source=openpr&utm_medium=ss

In addition, R&D activities related to hypertension drugs is expected to present new opportunities during the forecast period. However, patent expiry of antihypertensive drugs, such as Benicar and Diovan, may hinder the market growth. Furthermore, stringent government regulations, adverse effects of these drugs, and the high cost of healthcare leading to undiagnosed hypertension restrict the market.

The market is segmented on the basis of type and geography. Based on the type, the market is divided into diuretics, beta blockers, angiotensin-converting enzyme (ACE) inhibitors, alpha-beta blockers, angiotensin II receptor blockers, aldosterone antagonists, calcium channel blockers, renin inhibitors, alpha blockers, central-acting agents, vasodilators, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Make an Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2647?utm_source=openpr&utm_medium=ss

Major Players:

• Actelion Ltd.
• Novartis AG
• Pfizer Inc.
• Johnson &Johnson Ltd.
• Sanofi SA
• Lupin Limited
• Merck & Co.
• AstraZeneca Plc.
• Gilead Sciences Inc.
• GlaxoSmithKline Plc

Key Benefits:

• The study provides an in-depth analysis of the global Alprazolam powder market, with current trends and future estimations to elucidate the investment pockets.

• Comprehensive analysis of factors that drive and restrict the growth of the market is provided.

• The report presents a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.

• Extensive analysis of different segments facilitates to understand various products of the market.

• Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.

Browse More Details of Report @ https://www.alliedmarketresearch.com/hypertension-drug-market?utm_source=openpr&utm_medium=ss

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.